Novartis Whistleblower Suit Over MS Drug Dismissed With Leave To Amend

Mealey's (April 17, 2020, 8:50 AM EDT) -- NEW YORK — A New York federal judge on March 24 dismissed with leave to amend a false claims complaint alleging that Novartis Pharmaceuticals Corp. used a sham speaker program to...
To view the full article, register now.